Park MS, Yang AY, Lee JE, Kim SK, Roe J-S, Park M-S, Oh MJ, An HJ, Kim M-Y
As part of this, the NHS will ensure that in line with the Armed Forces Covenant, those in the armed forces, reservists, their families and veterans are not disadvantaged Improving lives
Blog Post Posted: 14th July 2025 BPC-157 (short for Body Protection Compound 157 ) is a synthetic peptide based on a naturally occurring compound in your own gastric juices
Because this treatment is safe for everyone, it does not have any side effects risks or medical restrictions
Phase 3 monotherapy available Feature Expected GI burden Cagrilintide + Retatrutide Very high CagriSema (Cag + Sema) High Retatrutide Alone High Feature Dysesthesia risk Cagrilintide + Retatrutide Yes (retatrutide component) CagriSema (Cag + Sema) No Retatrutide Alone Yes Feature Injections per week Cagrilintide + Retatrutide 2 (separate) or 1 (pre-blend) CagriSema (Cag + Sema) 1 or 2 Retatrutide Alone 1 Feature Regulatory status Cagrilintide + Retatrutide Neither approved